Literature DB >> 17269972

Lobomycosis in Venezuela.

Alberto E Paniz-Mondolfi1, Oscar Reyes Jaimes, Luisana Dávila Jones.   

Abstract

Lobomycosis is a chronic dermal infection that presents a wide spectrum of clinical- dermatological manifestations, mainly characterized by the development of keloid lesions as well as nodular, verrucoid and sometimes ulcerous forms. The etiological agent at an international level, according to the consensus nomenclature, has been called Loboa loboi, even though recently it has been accommodated as Lacazia loboi. The present review extensively covers the clinical-epidemiological aspects as well as the most outstanding historical aspects, including the Venezuelan experience and the presentation of two new cases, which substantiate the Amazon basin as an endemic area for the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17269972     DOI: 10.1111/j.1365-4632.2007.02937.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

Review 1.  Jorge Lobo's disease: a case of keloidal blastomycosis (lobomycosis) in a nonendemic area.

Authors:  Rezina Arju; Jiten P Kothadia; Monica Kaminski; Sherly Abraham; Shah Giashuddin
Journal:  Ther Adv Infect Dis       Date:  2014-06

2.  Subcutaneous Mycoses in Travelers.

Authors:  Andrés Tirado-Sánchez; Carlos Franco-Paredes; Alexandro Bonifaz
Journal:  Curr Trop Med Rep       Date:  2020-11-06

Review 3.  Lobomycosis Epidemiology and Management: The Quest for a Cure for the Most Neglected of Neglected Tropical Diseases.

Authors:  Franciely G Gonçalves; Patrícia S Rosa; Andrea de F F Belone; Léia B Carneiro; Vania L Q de Barros; Rosineide F Bispo; Yally A da S Sbardelott; Sebastião A V M Neves; Amy Y Vittor; William J Woods; Gabriel Z Laporta
Journal:  J Fungi (Basel)       Date:  2022-05-10

4.  Lobomycosis: A case from Southeastern Europe and review of the literature.

Authors:  Evangelia Papadavid; Maria Dalamaga; Irini Kapniari; Ekaterini Pantelidaki; Sotirios Papageorgiou; Vassiliki Pappa; Panagiotis Tsirigotis; Ioannis Dervenoulas; Nikolaos Stavrianeas; Dimitrios Rigopoulos
Journal:  J Dermatol Case Rep       Date:  2012-09-28

5.  Lobomycosis in man and lobomycosis-like disease in bottlenose dolphin, Venezuela.

Authors:  Luis Bermudez; Marie-Françoise Van Bressem; Oscar Reyes-Jaimes; Alejandro J Sayegh; Alberto E Paniz-Mondolfi
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

6.  Case Report: Molecular Confirmation of Lobomycosis in an Italian Traveler Acquired in the Amazon Region of Venezuela.

Authors:  Anna Beltrame; Patrizia Danesi; Claudio Farina; Pierantonio Orza; Francesca Perandin; Claudia Zanardello; Paola Rodari; Silvia Staffolani; Zeno Bisoffi
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

Review 7.  Lobomycosis: epidemiology, clinical presentation, and management options.

Authors:  Valeska Albuquerque Francesconi; Ana Paula Klein; Ana Paula Botelho Gualda Santos; Rajendranath Ramasawmy; Fábio Francesconi
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

8.  Lobomycosis in Soldiers, Colombia.

Authors:  Claudia M Arenas; Gerzain Rodriguez-Toro; Andrea Ortiz-Florez; Ingrid Serrato
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

9.  Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity.

Authors:  Michelle de C S Azevedo; Patricia S Rosa; Cleverson T Soares; Luciana R V Fachin; Ida Maria F D Baptista; William J Woods; Gustavo P Garlet; Ana Paula F Trombone; Andrea de F F Belone
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.